Supplementary Material - Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet in a real-world setting: 2-year interim analysis of a specified drug-use survey

Supplementary Table S1. Mite antigen allergy tests performed in patients per analysis set.

Data are expressed as n (%).

^a Patients had been diagnosed at other hospital before entering the survey study.

CAP-RAST, ImmunoCAP Specific IgE blood test (CAP)-radioallergosorbent test (RAST); MAST-33, Multiple Antigen Simultaneous Test; View-36, Multiple (36) antigen test.